Apr 13, 2016 ... 2014-06634. DECISION & ORDER. New York Community Bank, appellant, v Daphne. McClendon, respondent, et al., defendants. (Index No.
Dec 21, 2000 ... ... (prevalence ratio, 1.23 [95 percent confidence interval, 1.08 to 1.40]) and a relatively low rate of survival at one year (38 percent, vs.
Since many AMLs are hierarchically organized (Lapidot et al., 1994; Yilmaz et al., 2006), and driver mutations influence the .... Fate versus potential in cancer.
Contrasting overall outcomes, i.e. increased plant growth versus plant growth arrest, .... network originating in the chloroplast, see the studies of Munné-Bosch et al. ..... McMillen GG, McClendon JH. ... Adir N, Zer H, Shochat S, Ohad I. 2003.
May 6, 2013 ... Abstract. Cushing's disease (CD) is a condition of chronic hypercortisolism caused by an adrenocorticotropic hormone-secreting pituitary ...
Cite this article as: Wikstrand, C.J., Cokgor, I., Sampson, J.H. et al. Cancer Metastasis Rev (1999) 18: 451. doi:10.1023/A:1006354102377. 32 Citations; 76 ...
It is important to use these abbreviations literally and to punctuate them correctly. Many writers confuse "e.g." and "i.e.," and many type "et al." improperly or do ...
Feb 4, 2011 ... Third on the list is the usage of et al. Given the level of detail in these style rules, it's no surprise that many find them challenging. Here are three ...
Oct 24, 2014 ... Using a differential equation model, Johnston et al. showed that any ..... R. E. McLendon, D. Corbeil, A. Chenn, A. B. Hjelmeland, D. M. Park and .... V. Castillo, R. Valenzuela, C. Huidobro, H. R. Contreras and E. A. .... D. Hart, E. Shochat and Z. Agur, Br. J. Cancer, 1998, 78, 382–387 CrossRef CAS PubMed .
Oct 15, 2009 ... tors and immunoglobulin molecules via V(D)J recombination. ..... Bao S, Wu Q, McLendon RE, et al. Glioma .... Harris N, Brill E, Shohat O, et al.